Search

Your search keyword '"Pomeroy, Emily J."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Pomeroy, Emily J." Remove constraint Author: "Pomeroy, Emily J."
31 results on '"Pomeroy, Emily J."'

Search Results

1. Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

3. PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma

4. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency

7. CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells

12. Supplementary Data from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

13. Data from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

14. Table S2 from Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

15. Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production

16. Ablation of SYK kinase from primary human Natural Killer cells via CRISPR/Cas9 enhances cytotoxicity and cytokine production

19. Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma

20. Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments

21. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

22. Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors

23. A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

24. An Indole–Chalcone Inhibits Multidrug-Resistant Cancer Cell Growth by Targeting Microtubules

26. Targeting Ras signaling in AML: RALB is a small GTPase with big potential.

28. Multiplex Prime Editing and PASSIGE TMfor Non-Viral Generation of an Allogeneic CAR-T Cell Product

31. Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.

Catalog

Books, media, physical & digital resources